| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| (S)-[(1S,2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](quinolin-4-yl)methanol |
辛可寧 |
118-10-5 |
詳細
|
| Canagliflozin |
卡格列凈 |
842133-18-0 |
詳細
|
| Ipragliflozin |
伊格列凈 |
761423-87-4 |
詳細
|
| (2S,3S)-2,3-bis(benzoyloxy)butanedioic acid; (3R)-3-cyclopentyl-3-[4-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |
魯索利替尼中間體 |
1236033-04-7 |
詳細
|
| Zamicastat |
Zamicastat |
1080028-80-3 |
詳細
|
| N-[2-[(3S)-3-[[cis-4-hydroxy-4-(5-pyrimidin-2-yl-2-pyridyl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxo-ethyl]-3-(trifluoromethyl)benzamide |
N-(2 - ((S)-3 - (((1R,4S)-4-羥基-4-(5-(嘧啶-2-基)吡啶-2-基)環(huán)己基)氨基)吡咯烷-1-基)-2-氧代乙基)-3-(三氟甲基)苯甲酰胺 |
1372407-07-2 |
詳細
|
| Clemastine fumarate |
富馬酸氯馬斯汀 |
14976-57-9 |
詳細
|
| (-)-Epicatechin |
表兒茶素 |
490-46-0 |
詳細
|
| 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide |
利巴韋林 |
36791-04-5 |
詳細
|
| (S,S)-Hydrobenzoin |
(S,S)-(-)-氫化苯偶姻 |
2325-10-2 |
詳細
|
| 2,4,7-trichloro-8-fluoro-pyrido[4,3-d]pyrimidine |
2,4,7-三氯-8-氟吡啶并[4,3-D]嘧啶 |
2454396-80-4 |
詳細
|
| Tofacitinib |
托法替尼 |
477600-75-2 |
詳細
|
| Lenvatinib |
樂伐替尼 |
417716-92-8 |
詳細
|
| Ibrutinib |
依魯替尼 |
936563-96-1 |
詳細
|
| Ponatinib |
帕納替尼 |
943319-70-8 |
詳細
|
| PF-06840003 |
3-(5-氟-1H-吲哚-3-基)-2,5-吡咯烷二酮 |
198474-05-4 |
詳細
|
| TCMDC 123865 |
特拉唑嗪雜質(zhì)E |
102839-00-9 |
詳細
|
| AP26113 |
AP26113 |
1197958-12-5 |
詳細
|
| AZD-5363 |
4-氨基-N-[(1S)-1-(4-氯苯基)-3-羥基丙基]-1-(7H-吡咯并[2,3-D]嘧啶-4-基)-4-哌啶甲酰胺 |
1143532-39-1 |
詳細
|
| N-[cis-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]cyclobutyl]propane-1-sulfonamide |
PF-04965842(阿布羅替尼) |
1622902-68-4 |
詳細
|
| Aficamten |
AFICAMTEN |
2364554-48-1 |
詳細
|
| NSC 60534 |
1,4-二氧六環(huán)-2-酮 |
3041-16-5 |
詳細
|
| Tadalafil |
他達拉非 |
171596-29-5 |
詳細
|
| Ertugliflozin |
埃格列凈 |
1210344-57-2 |
詳細
|
| Rociletinib |
CO1686 |
1374640-70-6 |
詳細
|
| Acalabrutinib |
阿卡替尼 |
1420477-60-6 |
詳細
|
| E-7046 |
E-7046 |
1369489-71-3 |
詳細
|
| Reldesemtiv |
CK-2127107 |
1345410-31-2 |
詳細
|
| 2-bromo-1-[(3R,5R,8R,9R,10S,13S,14S,17S)-3-hydroxy-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone |
2-溴-1-((3R,5R,8R,9R,10S,13S,14S,17S)-3-羥基-3,13-二甲基十六氫-1H-環(huán)戊二烯并[A]菲-17-基)乙酮 |
1430063-93-6 |
詳細
|
| Benztropine mesylate |
苯扎托品 |
132-17-2 |
詳細
|
| 3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(3S,4R)-4-hydroxy-2-oxo-pyrrolidin-3-yl]propanamide |
化合物INAXAPLIN |
2446816-88-0 |
詳細
|
| DTBQ |
3,5-二叔丁基鄰苯醌 |
3383-21-9 |
詳細
|
| Ivacaftor |
依伐卡托 |
873054-44-5 |
詳細
|
| Cobimetinib |
考比替尼 |
934660-93-2 |
詳細
|
| BAY-41-8543 |
BAY-41-8543 |
256498-66-5 |
詳細
|
| PRT 062607 |
化合物 T24584 |
1370261-98-5 |
詳細
|
| CLP 290 |
2{[(5Z)2(1,2diazinan1yl)4oxo4,5dihydro1,3thiazol5ylidene]Methyl}5fluorophenyl pyrrolidine1carboxylate |
1181083-81-7 |
詳細
|
| 4-hydroxy-2-methoxy-benzaldehyde |
4-羥基-2-甲氧基苯甲醛 |
18278-34-7 |
詳細
|
| Riluzole |
利魯唑 |
1744-22-5 |
詳細
|
| tert-butyl 2-[(5-fluoro-2-pyridyl)oxymethyl]-8-azabicyclo[3.2.1]octane-8-carboxylate |
2-((((5-氟吡啶-2-基)氧基)甲基)-8-氮雜雙環(huán)[3.2.1]辛烷-8-羧酸叔丁酯 |
2007919-75-5 |
詳細
|
| PF-06882961 |
PF-06882961 |
2230198-02-2 |
詳細
|
| Lopinavir |
洛匹那韋 |
192725-17-0 |
詳細
|
| (2R,3R,4R)-3,4-bis(acetyloxy)-3,4-dihydro-2H-pyran-2-yl]methyl acetate |
D-三乙酰半乳糖烯 |
4098-06-0 |
詳細
|
| tasimelteon |
他司美瓊 |
609799-22-6 |
詳細
|
| Telaprevir |
特拉匹韋（VX-950） |
402957-28-2 |
詳細
|
| 2-[4-(3-methylpyrazin-2-yl)phenyl]-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide |
TTA-A8 |
1146395-46-1 |
詳細
|
| N-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3S)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-3-yl)pyridine-3-carboxamide |
N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3S)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-3-yl)pyridine-3-carboxamide |
1492952-73-4 |
詳細
|
| Gemcitabine |
吉西他濱 |
95058-81-4 |
詳細
|
| OWL 833 |
GLP-1 receptor agonist 1 |
2212020-52-3 |
詳細
|
| N-[(2-methyl-4-{2-[(1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}phenyl)methyl]-3-(propan-2-yloxy)azetidine-1-carboxamide |
BIIB068 |
1798787-27-5 |
詳細
|
| NSC 39655 |
2-氨基二苯醚 |
2688-84-8 |
詳細
|
| 4-[[(2S,3R,4R,5S)-3-(3,4-difluoro-2-methoxy-phenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carbonyl]amino]pyridine-2-carboxamide |
|
2649467-57-0 |
詳細
|
| sotagliflozin |
索格列凈 |
1018899-04-1 |
詳細
|
| 1-[[(2R,3S)-2-(2,4-difluorophenyl)-3-methyl-oxiran-2-yl]methyl]-1,2,4-triazole |
1-(((2R,3S)-2-(2,4-二氟苯基)-3-甲基環(huán)氧乙基-2-基)甲基)-1H-1,2,4-三唑 |
127000-90-2 |
詳細
|
| Empagliflozin |
恩格列凈 |
864070-44-0 |
詳細
|
| Enasidenib |
恩西地平 |
1446502-11-9 |
詳細
|
| AQW-051 |
AQW-051 |
669770-29-0 |
詳細
|
| GS 5734 |
瑞德西韋 |
1809249-37-3 |
詳細
|
| ABBV-744 |
ABBV-744 |
2138861-99-9 |
詳細
|
| Tetrabenazine |
丁苯那嗪 |
58-46-8 |
詳細
|
| SB-431542 |
SB-431542 |
301836-41-9 |
詳細
|
| Riociguat |
利奧西呱 |
625115-55-1 |
詳細
|
| Alectinib |
艾樂替尼 |
1256580-46-7 |
詳細
|
| 6-amino-4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-7-ethoxyquinoline-3-carbonitrile |
6-氨基-4-(3-氯-4-(吡啶-2-取代甲氧基)苯胺)-7-乙氧基喹啉-3-甲腈 |
848139-78-6 |
詳細
|
| Vortioxetine |
沃替西汀 |
508233-74-7 |
詳細
|
| Siponimod |
辛波莫德 |
1230487-00-9 |
詳細
|
| Lumateperone |
盧美哌隆 |
313368-91-1 |
詳細
|
| PF-06650833 |
PF-06650833 |
1817626-54-2 |
詳細
|
| Risdiplam |
利司撲蘭 |
1825352-65-5 |
詳細
|
| (1R)-6-fluoro-7-(2-fluoro-6-hydroxy-phenyl)-1-(2-isopropyl-4-methyl-3-pyridyl)-4-[(2S)-2-methyl-4-prop-2-enoyl-piperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one |
AMG510 單一構(gòu)型 |
2296729-00-3 |
詳細
|
| PLX-4720 |
N-[3-[(5-氯-1H-吡咯并[2,3-B]吡啶-3-基)羰基]-2,4-二氟苯基]-1-丙磺酰胺 |
918505-84-7 |
詳細
|
| GW-2580 |
GW2580 |
870483-87-7 |
詳細
|
| pilaralisib |
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺 |
934526-89-3 |
詳細
|
| GSK-356278 |
GSK-356278 |
720704-34-7 |
詳細
|
| Bempedoic acid |
貝派地酸 |
738606-46-7 |
詳細
|
| (Z)-4-amino-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide |
4-氨基-N-(3-溴-4-氟苯基)-N'-羥基-1,2,5-惡二唑-3-甲脒 |
914638-30-5 |
詳細
|
| ON-123300 |
8-環(huán)戊基-7,8-二氫-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈 |
1357470-29-1 |
詳細
|
| N-(cyclopropanesulfonyl)-4,4-dimethyl-2-[3-(morpholin-4-yl)phenyl]-1,2,3,4-tetrahydroquinoline-6-carboxamide |
N-(cyclopropanesulfonyl)-4,4-dimethyl-2-[3-(morpholin-4-yl)phenyl]-1,2,3,4-tetrahydroquinoline-6-carboxamide |
1391608-77-7 |
詳細
|
| 3-[[3-(cyclopropylsulfamoyl)-7-(2,4-dimethoxypyrimidin-5-yl)-4-quinolyl]amino]-5-(3,5-difluorophenoxy)benzoic acid |
1445879-21-9 |
1445879-21-9 |
詳細
|
| MTS |
1-甲氧基-1-(三甲基甲硅氧基)-2-甲基-1-丙烯 |
31469-15-5 |
詳細
|
| Encenicline enantiomer |
|
550999-76-3 |
詳細
|
| kd-025 |
2-[3-[4-[(1H-吲唑-5-基)氨基]喹唑啉-2-基]苯氧基]-N-異丙基乙酰胺 |
911417-87-3 |
詳細
|
| PF-04447943 |
PF 4447943 |
1082744-20-4 |
詳細
|
| BLU-9931 |
BLU 9931 |
1538604-68-0 |
詳細
|
| SP-13786 |
(S)-N-[2-(2-氰基-4,4-二氟-1-吡咯烷基)-2-氧代乙基]喹啉-4-甲酰胺 |
1448440-52-5 |
詳細
|
| PD-126055 free acid |
EMA401 |
1316755-16-4 |
詳細
|
| 6-fluoro-3-(7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-indole |
|
1802154-20-6 |
詳細
|
| NSC 33942 |
1,4-二溴苯 |
106-37-6 |
詳細
|
| pimavanserin |
匹莫范色林 |
706779-91-1 |
詳細
|
| Dapagliflozin |
達格列凈 |
461432-26-8 |
詳細
|
| methyl (4R)-4-[(7R,8S,9S,10R,13R,14S,17R)-7-(methoxymethoxy)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoate |
(R)-4-[(7R,8S,9S,10R,13R,14S,17R)-7-(甲氧基甲氧基)-10,13-二甲基-3-氧代-2,3,6,7,8,9,10,11,12,13,14,15,16,17-十四氫-1H-環(huán)戊并[A]菲-17-基]戊酸甲酯 |
610313-90-1 |
詳細
|
| Virgaureagenin B |
齊墩果酸 |
508-02-1 |
詳細
|
| flibanserin |
氟立班絲氨 |
167933-07-5 |
詳細
|
| Avanafil |
阿伐那非 |
330784-47-9 |
詳細
|
| Telotristat ethyl |
特羅司他乙酯 |
1033805-22-9 |
詳細
|
| (4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid |
膽酸 |
81-25-4 |
詳細
|
| Lifitegrast |
立他司特 |
1025967-78-5 |
詳細
|
| erlotinib |
埃羅替尼 |
183321-74-6 |
詳細
|
| Tamoxifen |
他莫昔芬 |
10540-29-1 |
詳細
|
| BC-1382 |
|
2197231-02-8 |
詳細
|